期刊文献+

17例肝豆状核变性病例分析 被引量:3

Clinical analysis of 17 cases of hepatolenticular degeneration
下载PDF
导出
摘要 目的探讨肝豆状核变性的临床特点,加深对该病的认识,提高早期诊断率。方法回顾性分析17例肝豆状核变性患者的临床资料。结果 17例患者(其中3例有明确的家族遗传史)平均发病年龄为(25.3±8.1)岁。其中10例以神经精神症状为主,6例以消化系统症状为主,1例表现为溶血性贫血。17例患者中13例K-F环阳性(76.5%),8例患者头颅MR I检查发现异常(47.1%),7例出现不同程度的转氨酶升高(41.2%),绝大部分出现血清铜和铜蓝蛋白含量减低。结论肝豆状核变性青少年多见,以神经系统和肝损害为主要表现,血清铜、铜蓝蛋白降低,角膜K-F环阳性是其重要改变。 Objective To investigate the manifestation of hepatolenticular degeneration,and improve the early diagnosis of this disease. Methods Seventeen cases of hepatolenticular degeneration were analyzed retrospectively.Results Three cases had a familial inheritance.Ten cases mainly presented neuropsychical disorder,and 6 cases presented digestive system symptom,and 1 case presented hemolyticanemia.In the 17 cases,13 patients(76.5%) had K-F rings.Eight cases 47.1% examining MRI of the brain were detected structural abnormalities.Seven cases(41.2%) had aminotransferases rising to varying degrees.Most patients decreased levels of serum copper and ceruloplasmin.Conclusion Hepatolenticular degeneration often occurs in adolescent,characterized by neurologic disease and liver injury.Decreased serum copper,Ceruloplasmin and Kayser-Fleischer rings are important characteristics.
出处 《胃肠病学和肝病学杂志》 CAS 2011年第2期156-157,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 肝豆状核变性 临床表现 血清铜 铜蓝蛋白 青霉胺 Hepatolenticular degeneration Clinical manifestation Serum copper Ceruloplasmin D-penicillamine
  • 相关文献

参考文献12

  • 1王宇,赵新颜,欧晓娟,贾继东.30例肝豆状核变性病例的临床分析[J].胃肠病学和肝病学杂志,2010,19(9):864-867. 被引量:4
  • 2Sternlieb I. Wilson's disease [J].Clin Liver Dis, 2000, 4(1 ) : 229- 239.
  • 3无.肝豆状核变性的诊断与治疗指南[J].中华神经科杂志,2008,41(8):566-569. 被引量:260
  • 4梁秀龄.解读《肝豆状核变性的诊断与治疗指南》[J].中国现代神经疾病杂志,2009,9(3):212-215. 被引量:36
  • 5Steindl P, Ferenci P, Dienes HP, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge [ J]. Gastroenterology, 1997, 113(1): 212-218.
  • 6Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update [J].Hepatology, 2008, 47(6): 2089 -2111.
  • 7Fleming CR, Dickson ER, Wahner HW, et al. Pigmented corneal rings in non-Wilsonian Liver disease [J].Ann Intern Med, 1977, 86 (3) : 285 -288.
  • 8Duma LL, Annable WL, Kliegman RM. Pigmented corneal rings in neonates with liver disease[J].J Pediatr, 1987, 110(5) : 771-776.
  • 9Sinha S, Taly AB. Withdrawal of penicillamine from zinc sulphate-penicillamine main e la ee thera;ov in Wilson's disease: Promising, safe and cheap [J]. J Neurol Sci, 2008, 264(1-2) : 129-132.
  • 10Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zine XVI: treatment during the pediatric years [J].J Lab Clin Med, 2001 , 137(3) : 191-198.

二级参考文献39

  • 1梁秀龄,陈曦,李洵桦,黄丽,石铸,汤其强.肝豆状核变性临床若干问题[J].中华神经科杂志,2005,38(1):57-59. 被引量:54
  • 2黄丽,李洵桦,梁秀龄,李爱萍,庄甲军.各种辅助检查对肝豆状核变性的诊断价值[J].临床神经病学杂志,2006,19(1):8-11. 被引量:23
  • 3梁秀龄.肝豆状核变性诊断与治疗中需注意的问题[J].中国现代神经疾病杂志,2007,7(1):4-8. 被引量:7
  • 4Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet, 2007, 369:397-405.
  • 5Figus A, Angius A, Loudianos G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet, 1995, 57: 1318-1324.
  • 6Roberts EA, Schilsky ML; Division Gastroenterology and Nutrition. A practice guideline on Wilson disease. Hepatology, 2003, 37 : 1475-1492.
  • 7Wilson DC ,Phillips M J, Cox DW, et al. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr, 2000, 137: 719- 722.
  • 8Ala A, Borjigin J, Rochwarger A, et al. Wilson disease in septuagenarian siblings : Raising the bar for diagnosis. Hepatology, 2005, 41:668-670.
  • 9Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int, 2003,23 : 139-142.
  • 10Sinha S ,Taly AB. Withdrawal of peniciUamine from zinc sulphatepenicillamine maintance therapy in Wilson's disease : promising, safe and cheap. J Neurol Sci, 2008,264: 129-132.

共引文献285

同被引文献26

  • 1Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet, 2007,369 :397 408.
  • 2Steindl P,Ferenci P,Dienes HP, et al. Wilsons disease in patients presenting with liver disease: a diagnostic challenge. Gastroenter- ology, 1997, 113:212-218.
  • 3Fleming CR, Dickson ER, Wahner HW, et al. Pigmented corneal rings in non Wilson an liver disease. Ann Intern Med, 1977, 86: 285 -288.
  • 4Dunn LL, Annable WL,Kliegman RM. Pigmented coneal rings in neonatesw it h liver disease. J Pediatr, 1987, 110 : 771-776.
  • 5Wu ZY, Lin MT, Murong SX, et al. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with wil sons disease. Arch Neurol, 2003,60: 737 741.
  • 6Park HD, Park HK, Chung H S, et al. Association of ATP7B mutation detection rate with biochemical characteristics in Korean patients with Wilson disease. Ann Clin Lab Sc, 2010, 4(): 15-19.
  • 7Roberts EA, Schilsky ML. American Association for Study of Liv- er Diseases (AASLD). Diagnosis and treatment o: Wilson disease: an update. Hepatology, 2008, 47:2089 2111.
  • 8Xu H,Sakakibara S,Morifuji M, et al. Excess dietary histidine de- creases the liver copper level and serum alanine amino transferase activity in Long- Evans Cinnamon rats. Br J Nutr,2003,90:573 579.
  • 9Zhang L, Lichtmaneger J, Summer KH, et al. Tracing copper-thio- molybdate complexes in a prospective treatment for Wilsons dis ease. Biochemistry,2009,48: 891 897.
  • 10I.inn FH, Houwen RH, van HJ, et al. Long term exclusive in emono therapy in symptomatic Wilson disease: experience in 17patients. Hepatology,2009,50:1442 1452.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部